Infections, Respiratory Clinical Trial
Official title:
A Randomized, Placebo-controlled Study of the Tolerability, Safety and Pharmacokinetics of PA in Healthy Volunteers
This is a first-in-human (FIH) study to explore the safety, tolerability and pharmacokinetics of PA after oral ascending dose administration to healthy male volunteers.
The first-in-human dose (FHD) trial is a randomized, double-blind, placebo-controlled,
dose-escalation trial assessing safety, tolerability and pharmacokinetics (PK) of single and
multiple oral doses of PA in healthy male subjects.
The study consists of two stages: single dose administration and multiple dose
administration.
The single dose administration stage includes 5 cohorts, multiple dose administration stage
includes at least 4 cohorts (groups). Each cohort includes 8 subjects (6 active drugs and 2
placebos). Cohorts intake ascending doses of study drug. The dose of 1st cohort is 1,0 mg/ml,
the doses for the following cohorts will be estimated by the Data Monitoring Committee based
on pharmacokinetics and safety results of previous group.
For each subject study includes screening period, one baseline period on Day -1, a treatment
period (1 day - at single dose stage; 14 days - at multiple dose stage), followed by safety,
PK, assessments up to 72-96 hours post dose. Follow-up visits will take place on Day 7 ; 30;
60 (single dose stage) and 30; 60; 90 (multiple dose stage).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00760851 -
Yogurt Study in Children 2-4 Years Old Attending Daycare
|
Phase 3 | |
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
| Completed |
NCT04321369 -
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
|
||
| Completed |
NCT03631342 -
Comparison Between Different Ventilator Hyperinflation Maneuvers
|
N/A | |
| Recruiting |
NCT03440216 -
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
|
N/A | |
| Recruiting |
NCT05661032 -
Novel Technologies for Respiratory Virus Identification
|
||
| Completed |
NCT04782427 -
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
|
||
| Completed |
NCT04591873 -
Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department
|
||
| Not yet recruiting |
NCT05721183 -
Evaluation of the National Tool for Observation of Infection Prevention Measures in the Healthcare (NOST)
|
N/A | |
| Completed |
NCT03996967 -
Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
|
||
| Completed |
NCT04649957 -
Profiling Recovery of Those Discharged Into the Community With COVID-19
|
||
| Active, not recruiting |
NCT04380701 -
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT02812914 -
NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health
|
N/A |